James E. Herndon

Research interests

Publications

• Recurrent Glioblastoma Treated with Recombinant Poliovirus

  New England Journal of Medicine · 2018 · 10.1056/nejmoa1716435

• Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors

  Nature Medicine · 2018 · 10.1038/s41591-018-0135-2

• Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

  Nature · 2015 · 10.1038/nature14320

• TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL

  Neuro-Oncology · 2014 · 10.1093/neuonc/nou206.18

• Cardiopulmonary Function and Age-Related Decline Across the Breast Cancer Survivorship Continuum

  Journal of Clinical Oncology · 2012 · 10.1200/jco.2011.39.9014

• Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial

  The Lancet · 2010 · 10.1016/s0140-6736(10)61115-4

• Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2010.28.6963

• IDH1 and IDH2 Mutations in Gliomas

  New England Journal of Medicine · 2009 · https://doi.org/10.1056/nejmoa0808710

• Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2008.16.4855

• Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma

  Clinical Cancer Research · 2007 · https://doi.org/10.1158/1078-0432.ccr-06-2309

• Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

  Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2007.12.2440

• Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B

  Journal of Clinical Oncology · 2007 · 10.1200/jco.2006.07.3569

• Video-Assisted Thoracic Surgery Lobectomy: Report of CALGB 39802—A Prospective, Multi-Institution Feasibility Study

  Journal of Clinical Oncology · 2007 · 10.1200/jco.2007.12.6649

• Hepatic Arterial Infusion Versus Systemic Therapy for Hepatic Metastases From Colorectal Cancer: A Randomized Trial of Efficacy, Quality of Life, and Molecular Markers (CALGB 9481)

  Journal of Clinical Oncology · 2006 · 10.1200/jco.2005.03.8166

• Increased Regulatory T-Cell Fraction Amidst a Diminished CD4 Compartment Explains Cellular Immune Defects in Patients with Malignant Glioma

  Cancer Research · 2006 · 10.1158/0008-5472.can-05-3773

• Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial

  Annals of Surgical Oncology · 2006 · 10.1245/aso.2006.05.013

• Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial

  The Annals of Thoracic Surgery · 2006 · 10.1016/j.athoracsur.2005.06.066

• Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion

  CHEST Journal · 2005 · 10.1378/chest.127.3.909

• Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730)

  Journal of Clinical Oncology · 2004 · 10.1200/jco.2005.07.172

• Phase II Trial of Gefitinib in Recurrent Glioblastoma

  Journal of Clinical Oncology · 2003 · 10.1200/jco.2004.08.110

• Impact of Azacytidine on the Quality of Life of Patients With Myelodysplastic Syndrome Treated in a Randomized Phase III Trial: A Cancer and Leukemia Group B Study

  Journal of Clinical Oncology · 2002 · 10.1200/jco.2002.04.044

• Randomized Phase II Study of Cisplatin With Gemcitabine or Paclitaxel or Vinorelbine as Induction Chemotherapy Followed by Concomitant Chemoradiotherapy for Stage IIIB Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Study 9431

  Journal of Clinical Oncology · 2002 · 10.1200/jco.2002.03.054

• Staging Non-Small Cell Lung Cancer with Whole-Body PET

  Radiology · 1999 · 10.1148/radiology.212.3.r99se21803

• Factors Predictive of Survival Among 337 Patients With Mesothelioma Treated Between 1984 and 1994 by the Cancer and Leukemia Group B

  CHEST Journal · 1998 · 10.1378/chest.113.3.723

• Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial

  JNCI Journal of the National Cancer Institute · 1996 · 10.1093/jnci/88.17.1210

Current projects

No projects listed.